Molecular Imaging: Page 44

Novel PET tracer can aid Alzheimer's detection
By Wayne Forrest
Swedish and Dutch researchers have predicted that a new PET tracer called RO-948 may become the standard method for diagnosing Alzheimer's disease. They published their findings on 11 May in JAMA Neurology.
May 14, 2020
2020 05 14 16 42 0592 Brain Gears 400
EU sets aside 120M euros for COVID-19 research
By AuntMinnieEurope.com staff writers
The European Institute for Biomedical Imaging Research (EIBIR) has revealed that the European Commission is soon to launch a second emergency call for COVID-19 research proposals.
May 12, 2020
2019 03 18 21 52 0264 Eu Flag 400
PET tracer could more precisely diagnose Alzheimer's
By Wayne Forrest
A new PET tracer called RO-948 could become the standard method for diagnosing Alzheimer's disease, accurately differentiating the condition from other neurodegenerative diseases, according to a study published on 11 May in JAMA Neurology.
May 12, 2020
MR Solutions installs 7T PET/MRI unit in Norway
By AuntMinnieEurope.com staff writers
Imaging technology developer MR Solutions has installed its 7-tesla PET/MRI scanner at the University of Tromsø (UiT) in Norway.
May 7, 2020
2020 05 08 15 55 9638 Mr Solutions Pet Mri 20200508153057
Blue Earth Diagnostics brings Axumin to Slovakia
By AuntMinnieEurope.com staff writers
Molecular imaging company Blue Earth Diagnostics has completed the first commercial delivery of its Axumin (fluciclovine F-18) PET radiopharmaceutical in Slovakia.
April 21, 2020
2020 04 22 18 47 9460 Business Men Handshake 400
How can nuclear medicine help with COVID-19 pandemic?
By Wayne Forrest
Radiology departments have been working overtime since the outbreak of COVID-19. But how nuclear medicine can contribute to the healthcare of the world's populations remains somewhat unclear, according to an article published online on 7 April in Nuklearmedizin.
April 10, 2020
2020 04 09 22 04 9662 Covid Fdg Pet Ct Images Leutje 400
PSMA-PET/CT again shows prowess for prostate cancer
By Wayne Forrest
Prostate-specific membrane antigen (PMSA)-PET/CT could become the primary modality approach in confirming the extent of prostate cancer and the most efficient way to direct patients to the most appropriate treatment, according to a study published on 22 March in Lancet.
March 25, 2020
2019 05 03 20 23 2154 Prostate 3 D 400
AuntMinnieEurope.com Molecular Imaging Insider
By Wayne Forrest
March 22, 2020
PET can help predict survival in prostate cancer
By Wayne Forrest
German and Swiss researchers have developed a PET-based risk classification metric for prostate cancer patients to help predict their survival without disease recurrence. They published their findings on 16 March in the European Journal of Nuclear Medicine and Molecular Imaging.
March 22, 2020
2016 10 04 11 38 34 158 Prostate 400
FDG-PET helps forecast outcome in neuroendocrine tumors
By Wayne Forrest
FDG-PET/CT can be used to classify neuroendocrine tumor patients into different prognostic categories for peptide receptor radionuclide therapy, German researchers have found. The decision to perform FDG-PET/CT should be based on the grading, time course of the disease, speed of progression, total tumor mass, and other criteria, they say.
March 19, 2020
2019 12 13 19 51 1879 Carcinoid Neuroendocrine Tumor 400
PET tracks down causes of fever in children
By Tami Freeman, PhD
In children with fever of unknown origin, imaging studies are scarce and the usefulness of FDG-PET/CT remains uncertain. Now a Dutch team has examined a large group of children in an attempt to fill the knowledge void.
March 12, 2020
2020 03 12 18 48 4411 2020 03 13 Pet Fever 20200312182919
Eckert & Ziegler begins production of lutetium-177
By AuntMinnieEurope.com staff writers
Isotope technology developer Eckert & Ziegler said it has begun commercial production of carrier-free lutetium-177.
March 10, 2020
Previous Page
Page 44 of 124
Next Page